Loss of LKB1 Leads to Alteration of the Immune Microenvironment in Non-Small Cell Lung Cancer
abstract: The majority of non-small cell lung cancer (NSCLC) patients (70%) are diagnosed with adenocarcinoma versus other histological subtypes. These patients often present with advanced, metastatic disease and frequently relapse after treatment. The tumor suppressor, Liver Kinase B1, is frequent...
Other Authors: | |
---|---|
Format: | Dissertation |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/2286/R.I.29807 |